Overview
Registration
Agenda
Faculty
View Archive

Accreditation/
Credit Designation

2021 TCT | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR are sponsored by the Medical College of Wisconsin.

The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education to physicians.

The Medical College of Wisconsin designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Medical College of Wisconsin designates this activity for up to 1.00 hours participation for continuing education for allied health professionals.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Sanofi US.

Optimizing Outcomes in Multiple Myeloma and non-Hodgkin Lymphoma Through Effective Autologous Transplantation and Stem Cell Mobilization

Optimizing Outcomes in Multiple Myeloma and non-Hodgkin Lymphoma Through Effective Autologous Transplantation and Stem Cell Mobilization


Wednesday, February 10, 2021

Live, Interactive Virtual Webcast!

1:30 PM – 2:30 PM CST

Overview

For patients with lymphoma and multiple myeloma (MM), primary therapy is followed by high-dose chemotherapy with autologous stem cell transplantation (ASCT). Failure to adequately mobilize peripheral blood stem cells (PBSCs) may lead to treatment delays and failures, rendering some patients ineligible for the planned ASCT. Therefore, the need for management strategies that identify patients at risk in a timely manner and optimize their treatment algorithms to prevent mobilization failure is imperative. The rate at which the field of transplantation is continuing to evolve can make it challenging for physicians, including transplant specialists, to maintain an in-depth understanding of all the relevant recent changes that might have occurred in their field.

Optimizing Outcomes in Multiple Myeloma and non-Hodgkin Lymphoma Through Effective Autologous Transplantation and Stem Cell Mobilization (NHL) is a virtual symposium that will provide insights from experts on the latest evidence in the field of stem cell mobilization in the form of didactic sessions, panel discussions, and case presentations. This activity will help health care professionals maintain a state-of-the-art clinical practice by providing updates on how to optimize personalized approaches for stem cell mobilization among patients with MM and NHL while mitigating treatment-related toxicities.

Benefits of Attending

  • Improve your knowledge of current strategies for stem cell mobilization in patients with MM and NHL undergoing ASCT
  • Gain expert insight into recent clinical trial evidence regarding agents available to increase the efficacy of stem cell mobilization
  • Learn from the experts how to utilize optimal strategies to individualize stem cell mobilization outcomes in the context of mitigating treatment-related toxicities
  • Gain expert perspectives on integrating recent data into current clinical practice to optimize personalized approaches for stem cell mobilization among patients with MM and NHL

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Sanofi US.

Target Audience

This educational program is directed toward hematologists, oncologists, blood and marrow transplant specialists, transplant nurses, and other clinicians involved in the treatment of patients with MM and NHL.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Review current strategies for stem cell mobilization in patients with MM and NHL undergoing ASCT
  • Utilize optimal strategies to individualize stem cell mobilization outcomes in the context of mitigating treatment-related toxicities
  • Assess recent clinical trial evidence regarding agents available to increase the efficacy of stem cell mobilization
  • Integrate recent data into current clinical practice to optimize personalized approaches for stem cell mobilization among patients with MM and NHL

Program Chairs

Luciano J. Costa, MD, PhD
Luciano J. Costa, MD, PhD/strong>
Professor of Medicine Associate Director for Clinical Research O'Neal Comprehensive Cancer Center Chair Multiple Myeloma Working Group The University of Alabama at Birmingham Birmingham, AL
 
Ivana N. Micallef, MD
Ivana N. Micallef, MD
Consultant
Division of Hematology, Department of Internal Medicine
Mayo Clinic Rochester
Rochester, MN

Registration

2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
 
Registration Fee - Free

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

Meeting information is accurate at the time of posting.



Register

You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information


Registration Information


Professional Information


Specialties*

Submit
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
     12
3456789
10111213141516
17181920212223
24252627282930
31
Filter By